Animal genetics group Genus has continued to trade in line with expectations during the four months to 31 October.
The firm believes world agricultural markets have generally remained favourable for its customers and remains confident that its expectations for the full year will be met.
Adjusted operating profit continued to grow as expected, although this was partly offset by higher research and development (R&D) costs. The R&D costs were higher in part due to increased investment and slightly higher feed costs, while finance costs were lower.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
The firm was keen to emphasise the overall adjusted profit before tax for the period was well ahead of last year.
Net debt at the end of October 2011 was £69.3m, slightly higher than at 30 June and significantly lower than at the same time last year (£79.7m).
The share price was down 0.89% to 1,000p at 14:12.
In the doghouse: hundreds of investment funds are underperforming - is it time to sell?
News The latest Spot The Dog research from Bestinvest reveals 151 funds are failing to beat their benchmark. We reveal the worst performers
By Marc Shoffman Published
Nationwide: House prices creep up for the first time in over a year
Nationwide’s latest house price index reveals property prices are finally rising. Will this pattern continue in 2024?
By Vaishali Varu Published